Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

Urapidil Base is a white crystalline powder. When dissolved, it forms a clear, colorless solution that is free of particles.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

COPPER GLUCONATE is a copper salt of D-gluconic acid that displays a light blue to bluish-green color. It is prepared by the reaction of gluconic acid solutions with cupric oxide or basic cupric carbonate. According to the good manufacturing or feeding practice by the FDA, copper gluconate is used as a nutrient or dietary supplement and is generally recognized as safe for use at a level not exceeding 0.005 percent. Copper Gluconate can be used as a dietary supplement and as a nutrient. Copper aids in the absorption of iron, in the formation of red blood cells and the proper bone formation and maintenance.

Refarmed Chemicals takes pride in providing the pharmaceutical industry with high-quality Ticlopidine Hydrochloride, an essential antiplatelet medication used to prevent strokes and other significant blood clots in patients who have experienced a stroke or transient ischemic attack (TIA). Manufactured under stringent GMP certification, our Ticlopidine Hydrochloride is presented in tablet form, with a strength of 250 mg ensuring consistent dosing and efficacy. Our Ticlopidine Hydrochloride acts by hindering platelet function, thereby diminishing the aggregation essential to blood clot formation. This preventive approach serves as a critical intervention in the management of clot-related disorders, significantly improving patient outcomes. Physicians typically recommend a starting dose of 250 mg administered twice daily, emphasizing that food intake during administration reduces gastrointestinal discomfort. Monitoring patient response allows for personalized treatment adjustments to optimize therapeutic benefits while considering safety profiles. As with all pharmaceuticals, we duly note possible side effects, ranging from mild gastrointestinal issues to less common, yet more severe reactions like neutropenia or liver impairment. This necessitates caution in prescribing to populations with liver disease, a history of bleeding disorders, or inflammatory bowel disease. Continuous patient monitoring and drug interaction vigilance are paramount, especially concerning commonly used medications such as aspirin and warfarin. Compliant storage conditions entail keeping the Ticlopidine Hydrochloride tablets at room temperature (15°C to 30°C), shielded from light and moisture to maintain product integrity. Ticlopidine Hydrochloride is supplied as a generic medication, ensuring affordability without compromising quality. Embracing our commitment to patient safety and treatment adherence, we underline the significance of medical guidance before initiating or discontinuing use, with particular respect to special populations like pregnant or breastfeeding women. Rest assured, our partnership with the DKSH Group underlines a shared vision for growth and delivery of quality healthcare solutions that spans across Asia and beyond, cementing our position as a trusted supplier in the pharmaceutical landscape.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.